Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10035768 C5aR antagonists

Patent 10035768 was granted and assigned to ChemoCentryx on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 10 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11951214 Capsule formulations
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+273 characters)
Article

Patent abstract

Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.

Edits on 11 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11779576 Method of treating C3 glomerulopathy
Edits on 5 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11773091 6-5 fused rings as C5a inhibitors
Edits on 1 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 1 Oct, 2023
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Hiroko Tanaka0
Jay Powers0
Ju Yang0
Kevin Lloyd Greenman0
Manmohan Reddy Leleti0
Pingchen Fan0
Yandong Li0
Yibin Zeng0
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 27 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Apr, 2023
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 11 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11608336 Prodrugs of fused-bicyclic C5aR antagonists
0
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 2 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 2 Apr, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Edits on 15 Mar, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 15 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11603356 Amorphous form of a complement component C5a receptor
0
Edits on 3 Nov, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11485737 Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
0
Edits on 28 Oct, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Oct, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11479553 5-5 fused rings as C5a inhibitors
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Oct, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11478460 Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
0
Edits on 6 Oct, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Oct, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
ChemoCentryx
ChemoCentryx
0
Current Assignee
ChemoCentryx
ChemoCentryx
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100357680
Date of Patent
July 31, 2018
0
Patent Application Number
157228190
Date Filed
October 2, 2017
0
Patent Citations Received
‌
US Patent 10532982 Processes and intermediates in the preparation of C5aR antagonists
0
‌
US Patent 10562896 6-5 fused rings as C5a inhibitors
0
‌
US Patent 10660897 C5aR antagonists
0
‌
US Patent 10683294 5-5 fused rings as C5a inhibitors
0
‌
US Patent 10759807 Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
0
‌
US Patent 10828285 Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
0
‌
US Patent 11026935 Free base crystalline form of a complement component C5a receptor
0
‌
US Patent 11285138 Method of treating C3 glomerulopathy
0
‌
US Patent 11384079 6-5 fused rings as C5a inhibitors
0
‌
US Patent 11427541 Salt forms of a complement component C5A receptor
0
Patent Primary Examiner
‌
Rita J Desai
0
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022

Find more entities like US Patent 10035768 C5aR antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.